BERLIN (Reuters) – Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit.
Screening for HPV can help identify women who are at risk of developing cervical cancer at an earlier stage.
(Reporting by Rachel More, writing by Andrey Sychev)
